About this episode

Antony Odell discusses translating academic IP into a commercial medtech device and the responsibilities of an early-stage CEO.

In this episode of Medsider Radio, we sat down with Antony Odell , co-founder and CEO of Echopoint Medical . Echopoint is a London-based UCL spinout developing iKOr, an optical microcatheter for coronary diagnostics. Antony brings over 30 years of medtech experience across Johnson & Johnson, Fresenius, and Stryker, before transitioning into startups as CEO of Tayside Flow Technologies and Tissue Regenix. He holds a BSc in Physiology and Biochemistry. In this interview, Antony discusses translating academic IP into a commercial device, choosing early clinical sites to balance speed and learning, managing non-dilutive funding as a long-term discipline, and outlines the most important responsibilities of an early-stage medtech CEO. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. And if you’re ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical…

People in this episode

Host: Scott Nelson

Guest: Antony Odell

Topics covered

• medtech
• startups
• academic IP
• coronary diagnostics
• entrepreneurship

Keywords

• medtech
• startups
• academic IP
• coronary diagnostics
• entrepreneurship
• clinical sites
• non-dilutive funding

Mentioned in this episode

Organizations: Echopoint Medical, Johnson & Johnson, Fresenius, Stryker, Tayside Flow Technologies, Tissue Regenix

Places: London, UCL

More episodes of Medsider: Learn from Medtech and Healthtech Founders and CEOs

• Building Clinical Evidence Around Your Target Market: Interview with Teal Health CEO Kara Egan · June 8, 2026 · 56 min
• Solving for Healthcare’s Broken Doorway: Interview with OnMed CEO Karthik Ganesh · June 1, 2026 · 51 min
• Meeting Patients Where They Are: Interview with Clairity CEO Dr. Connie Lehman · May 25, 2026 · 50 min
• Why Early Revenue is the Most Credible Proof in Medtech: Interview with restor3d CEO Kurt Jacobus · May 11, 2026 · 55 min

Explore listener stats, chart rankings, contacts and more on the Medsider: Learn from Medtech and Healthtech Founders and CEOs podcast page.